Comparison Between Chromoendoscopy and Conventional Colonoscopy to Improve the Detection of Neoplasia in Patients With Ulcerative Colitis (UC)
Comparaison de la Chromo Endoscopie Virtuelle FICE (Fujinon Intelligent Chromoendoscopy) Avec la Coloscopie Conventionnelle Dans la détection de la Dysplasie Chez Patients Porteurs de Recto Colite ulcéro hémorragique (RCH).
1 other identifier
interventional
80
1 country
1
Brief Summary
The primary endpoint of the study will be to compare the accuracy of two procedures (FICE with target biopsies only, versus conventional white light colonoscopy with recommended targeted and random biopsies) in the endoscopic surveillance of patient with long-standing UC. Accuracy will be measured based on the number of patients with confirmed neoplasia using each technique. The combined histological outcome following the two procedures will represent the gold-standard diagnosis for each patient. Secondary outcomes will be the number of patients with false-positive findings, the number of neoplastic lesions detected, the number of false-positive lesions per patient for each technique and the total time required for each procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2008
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 31, 2008
CompletedFirst Posted
Study publicly available on registry
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 9, 2013
CompletedJune 1, 2022
May 1, 2022
3 years
December 31, 2008
May 30, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary endpoint of the study will be to compare the accuracy of two procedures (FICE with target biopsies only, versus conventional white light colonoscopy)
3 months between FICE and Conventional white light colonoscopy
Secondary Outcomes (2)
The goal is to detect more and earlier neoplastic lesions in order to influence patient management in terms of treatment (potential colectomy) and surveillance.
3 months between FICE and Conventional white light colonoscopy
To quantify the number of true positive and false positive lesions by comparing the number of targeted biopsies performed for suspicious lesions and the resulting histological findings.
3 months between FICE and Conventional white light colonoscopy
Study Arms (2)
A
ACTIVE COMPARATORConventional white light colonoscopy
B
EXPERIMENTALChromoendoscopy
Interventions
Eligibility Criteria
You may qualify if:
- Clinically and histologically verified UC
- Disease duration ≥ 8 years
- A Mayo score ≤ 8 with an endoscopic sub score ≤ 2
- CPAM affiliation
- Able to give written informed consent to participate in the study
You may not qualify if:
- Known intraepithelial neoplasia or colorectal cancer or any other active malignancy
- Previous colo-rectal surgery
- Non-treatable coagulopathy or hemostatic dysfunction (prothrombin index \< 50% of control or/and partial thromboplastin time \> 50 seconds and/or thrombopenia \< 60000 / mm3)
- Pregnancy
- Inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Departement d'Endoscopie digestive - Hopital Archet 2, CHU de Nice
Nice, 06202, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Geoffrey VANBIERVLIET, PH
Departement d'Endoscopie digestive, CHU de Nice
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 31, 2008
First Posted
January 1, 2009
Study Start
October 1, 2008
Primary Completion
September 26, 2011
Study Completion
November 9, 2013
Last Updated
June 1, 2022
Record last verified: 2022-05